Mon, July 22, 2024
[ 12:00 AM ] - WOPRAI
Mon, June 24, 2024
[ 12:00 AM ] - WOPRAI
Fri, December 22, 2023
[ 12:00 AM ] - WOPRAI
Tue, December 19, 2023
Thu, November 30, 2023
[ 12:00 AM ] - WOPRAI
Fri, May 12, 2023
[ 12:00 AM ] - WOPRAI
Wed, April 26, 2023
[ 12:00 AM ] - WOPRAI
Thu, April 13, 2023
[ 12:00 AM ] - WOPRAI
Wed, April 12, 2023
[ 12:00 AM ] - WOPRAI
Mon, January 23, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, January 6, 2023
[ 12:00 AM ] - WOPRAI
Wed, December 14, 2022
[ 12:00 AM ] - WOPRAI
Tue, November 29, 2022
[ 12:00 AM ] - WOPRAI
Mon, November 14, 2022
[ 12:00 AM ] - WOPRAI
Thu, November 10, 2022
[ 12:00 AM ] - WOPRAI
Mon, November 7, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, August 18, 2022
[ 12:00 AM ] - WOPRAI
Thu, August 11, 2022
[ 12:00 AM ] - WOPRAI
Thu, July 28, 2022
[ 12:00 AM ] - WOPRAI
Tue, July 26, 2022
[ 12:00 AM ] - WOPRAI
Wed, June 15, 2022
[ 12:00 AM ] - WOPRAI
Fri, May 13, 2022
[ 12:00 AM ] - WOPRAI
Wed, May 11, 2022
[ 12:00 AM ] - WOPRAI
Fri, May 6, 2022
Mani Foroohar Initiated (BNTC) at Buy and Held Target at $13 on, Jul 22nd, 2024
Mani Foroohar of Leerink Partners, Initiated "Benitec Biopharma Inc." (BNTC) at Buy and Held Target at $13 on, Jul 22nd, 2024.
Mani has made no other calls on BNTC in the last 4 months.
There are 2 other peers that have a rating on BNTC. Out of the 2 peers that are also analyzing BNTC, 0 agree with Mani's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Mani
- Yasmeen Rahimi of "Piper Sandler" Initiated at Buy and Held Target at $30 on, Thursday, June 13th, 2024
- Silvan Tuerkcan of "JMP Securities" Maintained at Buy with Increased Target to $16 on, Monday, April 22nd, 2024
Contributing Sources